Bionano Genomics Inc (BNGO)
0.9585
+0.08
(+8.54%)
USD |
NASDAQ |
May 01, 16:00
0.9676
+0.01
(+0.95%)
After-Hours: 20:00
Bionano Genomics Free Cash Flow: -126.87M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -126.87M |
September 30, 2023 | -132.43M |
June 30, 2023 | -135.82M |
March 31, 2023 | -127.42M |
December 31, 2022 | -128.12M |
September 30, 2022 | -118.78M |
June 30, 2022 | -109.26M |
March 31, 2022 | -92.94M |
December 31, 2021 | -73.39M |
September 30, 2021 | -58.75M |
June 30, 2021 | -49.46M |
March 31, 2021 | -44.21M |
December 31, 2020 | -38.31M |
Date | Value |
---|---|
September 30, 2020 | -35.61M |
June 30, 2020 | -31.94M |
March 31, 2020 | -31.07M |
December 31, 2019 | -29.59M |
September 30, 2019 | -24.29M |
June 30, 2019 | -23.23M |
March 31, 2019 | -20.03M |
December 31, 2018 | -20.28M |
September 30, 2018 | -19.26M |
June 30, 2018 | -18.96M |
March 31, 2018 | -21.20M |
December 31, 2017 | -21.84M |
Free Cash Flow Range, Past 5 Years
-135.82M
Minimum
Jun 2023
-23.23M
Maximum
Jun 2019
-74.29M
Average
-58.75M
Median
Sep 2021
Free Cash Flow Benchmarks
Bruker Corp | 243.20M |
Azenta Inc | 32.43M |
Harvard Bioscience Inc | 11.72M |
Akoya Biosciences Inc | -54.55M |
Singular Genomics Systems Inc | -74.62M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -29.78M |
Cash from Investing (Quarterly) | -55.37M |
Cash from Financing (Quarterly) | 68.48M |
Free Cash Flow Per Share (Quarterly) | -0.7657 |
Free Cash Flow to Equity (Quarterly) | -100.33M |
Free Cash Flow to Firm (Quarterly) | -26.82M |
Free Cash Flow Yield | -489.3% |